Contact us for enquiry
+91 - 880 062 9460

Top Selling
erlonat smart breath temonat lenalid geftinat Veenat
Latest News
Lorem ipsum dolor sit amet, conse faucibus enim

Lorem ipsum dolor sit amet, conse
ctetur adipiscing elit. Duis non faucibus enim

Lorem ipsum dolor sit amet, conse
ctetur adipiscing elit. Duis non faucibus enim faucibus enim.

Erlonat - Erlotinib

Erlonat (Erlotinib) is used to treat non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication and have not gotten better. Erlonat (Erlotinib) is also used in combination with another medication (gemcitabine [Gemzar]) to treat pancreatic cancer that has spread to nearby tissues or to other parts of the body. Erlotinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.

Strength : mg, 100 mg & 150 mg tablets in packing of 30 tablets of Bottles.
Dosages : Erlonat (Erlotinib) comes as a tablet to take by mouth. It is usually taken on an empty stomach once a day, at least 1 hour before or 2 hours after eating a meal or snack. Take Erlonat (Erlotinib) at around the same time every day. Take erlonat (erlotinib) exactly as directed.
Overdose : May lead to:-
  • diarrhea
  • rashes
ERLONAT TABLETS

Precautions & Warnings:

  • The medicine should not be taken without consulting the doctor if the patient has liver disease, lung or breathing problems (other than lung cancer).
  • Do not take aspirin, or products containing aspirin, unless prescribed by the doctor Patient must take Erlonat at substantial time gap, if antacids are also being taken If the patient is allergic to the medicine or any of its constituents, then intake is not suggestible.
  • Erlonat consumption should avoided if the patient is pregnant or breast feeding the child. Doctor consultation suggested for use of birth control during treatment with Erlonat. It is not yet established whether Erlonat passes into breast milk or not.

The following drugs may interact with Erlonat :
Atazanavir Nelfinavir Indinavir Saquinavir Ritonavir Rifampin Rifabutin Rifapentine Clarithromycin Nefazodone Telithromycin Troleandomycin Carbamazepine Phenobarbital Phenytoin Ketoconazole Itraconazole VoriconazoleSt. John's Wort Side effects of the medicine are as follows: Breathing Closing of the throat Swelling of the lips, tongue, face or hives Shortness of breath Increased coughing Fever and chest pain Severe or persistent nausea Vomiting and loss of appetite Diarrhea Eye pain or irritation Skin rash, dryness, itching and acne Weakness Blistering and peeling Dry or cracked skin Itching, tenderness or burning of the skin Growth of eyelashes on the inside of the eyelid Unusual bruising or bleeding Note: Erlonat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.